Eimskip: Updated Financial Calendar 2023
Eimskip's Financial Calendar published 23 December 2022 has been altered as follows: First quarter 2023 16 May...
Globe Newswire10-03-2023, 01:42
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami 15-04-2024, 19:00